Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities
SALT LAKE CITY, July 21, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
Pharmaceuticals, Biotechnology and Life Sciences
SALT LAKE CITY, July 21, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients Meeting with the U.S. FDA clarified steps and…
STOUGHTON, Mass., July 21, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host…
Anti-TROP-2 coupled to SN38 (a DNA polymerase inhibitor) (ESG-401) has received approval to begin clinical trials.ESG-401 addresses a highly unmet…
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 21, 2021 – Genmab A/S (Nasdaq: GMAB) announces under…
BURBANK, CA, July 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D,…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 21, 2021 (GLOBE…
COVID-19 patients with newly diagnosed SARS-CoV-2 infections were treated in this large Phase 2 efficacy trial in the United Kingdom.COVIDROPS™…
– Csiki has over two decades of experience in research and drug development of cancer immunotherapies -REDWOOD CITY, Calif., July…
NEWPORT, United Kingdom and AMSTERDAM, July 21, 2021 (GLOBE NEWSWIRE) — Nanopharm Ltd., an Aptar Pharma company and leader in…